How to buy Sinovac Biotech Ltd (SVA) shares in Australia
Learn how to easily invest in Sinovac Biotech Ltd shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Sinovac Biotech Ltd is a biotechnology business with stocks listed in the US. Sinovac Biotech Ltd shares (SVA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$6.47 – the same closing value as a week prior. Here's how to invest if you're based in Australia.
How to buy shares in Sinovac Biotech Ltd
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Sinovac Biotech Ltd. Find the share by name or ticker symbol: SVA. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Sinovac Biotech Ltd reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$6.47, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Sinovac Biotech Ltd, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Sinovac Biotech Ltd. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Sinovac Biotech Ltd key stats
- Compare share trading platforms
- Is Sinovac Biotech Ltd stock a buy or sell?
- Sinovac Biotech Ltd performance over time
- Are Sinovac Biotech Ltd shares over-valued?
- Sinovac Biotech Ltd's financials
- How volatile are Sinovac Biotech Ltd shares?
- Does Sinovac Biotech Ltd pay a dividend?
- Other common questions
Sinovac Biotech Ltd stock price (NASDAQ:SVA)Use our graph to track the performance of SVA stocks over time.
Sinovac Biotech Ltd shares at a glance
|52-week range||US$6.47 - US$6.47|
|50-day moving average||US$6.47|
|200-day moving average||US$6.47|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$0.971|
Where to buy Sinovac Biotech Ltd stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Sinovac Biotech Ltd stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sinovac Biotech Ltd price performance over time
|1 week (2022-01-06)||6.47|
|1 month (2021-12-16)||6.47|
|3 months (2021-10-15)||6.47|
|6 months (2021-07-16)||6.47|
|3 years (2019-01-16)||0.31%|
|5 years (2017-01-13)||7.65%|
Is Sinovac Biotech Ltd under- or over-valued?
Valuing Sinovac Biotech Ltd stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sinovac Biotech Ltd's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sinovac Biotech Ltd's P/E ratio
Sinovac Biotech Ltd's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Sinovac Biotech Ltd shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Sinovac Biotech Ltd's EBITDA
Sinovac Biotech Ltd's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$219.5 million (£0.0 million).
The EBITDA is a measure of a Sinovac Biotech Ltd's overall financial performance and is widely used to measure a its profitability.
Sinovac Biotech Ltd financials
|Revenue TTM||US$510.6 million|
|Operating margin TTM||42.26%|
|Gross profit TTM||US$443.4 million|
|Return on assets TTM||11.46%|
|Return on equity TTM||25.16%|
|Market capitalisation||US$642.4 million|
TTM: trailing 12 months
Sinovac Biotech Ltd share dividends
We're not expecting Sinovac Biotech Ltd to pay a dividend over the next 12 months.
Sinovac Biotech Ltd share price volatility
Over the last 12 months, Sinovac Biotech Ltd's shares have ranged in value from as little as US$6.47 up to US$6.47. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sinovac Biotech Ltd's is 0.0649. This would suggest that Sinovac Biotech Ltd's shares are less volatile than average (for this exchange).
Sinovac Biotech Ltd overview
Sinovac Biotech Ltd., a biopharmaceutical company, focuses in the research, development, manufacture, and commercialization of vaccines against human infectious diseases in the People's Republic of China. The company's product portfolio includes vaccines against hepatitis A and B; hand, foot, and mouth diseases caused by enterovirus 71 (EV71); seasonal influenza; H5N1 and H1N1 pandemic influenza; coronavirus; varicella; and mumps. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine to treat viral disease in human species; split viron pandemic influenza vaccine; and Inlive, an EV71 vaccine. The company also offers varicella, a vaccine to treat contagious infectious disease; pneumococcal polysaccharide vaccine, a vaccine to prevent streptococcus pneumoniae infections, such as pneumonia and septicemia; quadrivalent influenza vaccine, a vaccine to protect against two influenza A viruses and two influenza B viruses; and CoronaVac, a vaccine against COVID-19. In addition, its pipeline products include sabin inactivated polio vaccine, a vaccine to treat Poliomyelitis that has completed phase III clinical trial; and rubella vaccine. The company has collaboration agreements with GlaxoSmithKline Biologicals SA to develop combination vaccines containing measles for the China market; Tianjin CanSino Biotechnology Inc. to develop a pneumococcal vaccine; and Instituto Butantan to advance the clinical trials of CoronaVac, an inactivated vaccine candidate against COVID-19 to Phase III. Sinovac Biotech Ltd. was founded in 1993 and is headquartered in Beijing, the People's Republic of China.
Sinovac Biotech Ltd in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda
Frequently asked questions
More guides on Finder
Interview: RAQ founder talks Abbie Chatfield swim collection
RAQ Apparel founder Sophia Argyropoulos chats the inspo for Abbie Chatfield swimwear collab and the secret to finding the perfect bikini.
7 ways to elevate your home movie experience [SPONSORED] Turn your low-key movie nights into a main attraction that can keep everyone entertained.
American Express Qantas Corporate Gold Card
With a 100,000 bonus Membership Rewards offer and complimentary Qantas Business Rewards membership, is this the right card for your business?
How to watch Liverpool vs Arsenal Carabao Cup live and free in Australia
Liverpool and Arsenal battle for a place in the League Cup final.
Rapid antigen tests: When will RAT stock be available? [UPDATED]
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
New on Netflix, Prime Video, Disney Plus, Stan, Foxtel, BINGE and more in January 2022
You can easily elevate your binge-watching game in the New Year.
Where to watch DC series Peacemaker online in Australia
He believes in peace at any cost – no matter how many people he has to kill to get it.
How to watch Melbourne Renegades vs Melbourne Stars BBL live and match preview
Both Melbourne teams are fighting for their seasons as we embark on derby number 2
10 beauty trends that’ll pop off in 2022
From clean beauty to bedazzled everything, these are the makeup looks will take over 2022 and the products you need to pull them off.
Compare rapid antigen test brands: How do they stack up?
Not all tests are created equal here are the different brands compared.
Ask an Expert